131 related articles for article (PubMed ID: 15196675)
21. Co-circulating sleep substances interactingly modulate sleep and wakefulness in rats.
Inoué S; Kimura-Takeuchi M; Honda K
Endocrinol Exp; 1990 Mar; 24(1-2):69-76. PubMed ID: 2361467
[TBL] [Abstract][Full Text] [Related]
22. The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent.
Murillo-Rodríguez E; Millán-Aldaco D; Palomero-Rivero M; Mechoulam R; Drucker-Colín R
Behav Neurosci; 2008 Dec; 122(6):1378-82. PubMed ID: 19045957
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption.
Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M
J Psychopharmacol; 2009 Jul; 23(5):475-86. PubMed ID: 19395429
[TBL] [Abstract][Full Text] [Related]
24. Effect of delta sleep inducing peptide (DSIP) and arginine vasotocin (AVT) on sleep and motor activity in the rat.
Tobler I; Borbély AA
Waking Sleeping; 1980; 4(2):139-53. PubMed ID: 7405185
[TBL] [Abstract][Full Text] [Related]
25. Effects of melatonin and 5-methoxytryptamine on sleep-wake patterns in the male rat.
Mirmiran M; Pévet P
J Pineal Res; 1986; 3(2):135-41. PubMed ID: 3459865
[TBL] [Abstract][Full Text] [Related]
26. Effects of chlorogenic acid and its metabolites on the sleep-wakefulness cycle in rats.
Shinomiya K; Omichi J; Ohnishi R; Ito H; Yoshida T; Kamei C
Eur J Pharmacol; 2004 Nov; 504(3):185-9. PubMed ID: 15541420
[TBL] [Abstract][Full Text] [Related]
27. Behavioural effects of dimethyl sulfoxide (DMSO): changes in sleep architecture in rats.
Cavas M; Beltrán D; Navarro JF
Toxicol Lett; 2005 Jul; 157(3):221-32. PubMed ID: 15917147
[TBL] [Abstract][Full Text] [Related]
28. D(1)/D(2) receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice.
Qiu MH; Qu WM; Xu XH; Yan MM; Urade Y; Huang ZL
Pharmacol Biochem Behav; 2009 Nov; 94(1):16-23. PubMed ID: 19604496
[TBL] [Abstract][Full Text] [Related]
29. Monoaminergic system lesions increase post-sigh respiratory pattern disturbance during sleep in rats.
Saponjic J; Radulovacki M; Carley DW
Physiol Behav; 2007 Jan; 90(1):1-10. PubMed ID: 16989875
[TBL] [Abstract][Full Text] [Related]
30. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
[TBL] [Abstract][Full Text] [Related]
31. MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.
Gyongyosi N; Balogh B; Kirilly E; Kitka T; Kantor S; Bagdy G
Brain Res; 2008 Sep; 1231():34-46. PubMed ID: 18638459
[TBL] [Abstract][Full Text] [Related]
32. Tonic activity of alpha1 adrenergic receptors of the medial preoptic area contributes towards increased sleep in rats.
Vetrivelan R; Mallick HN; Kumar VM
Neuroscience; 2006; 139(3):1141-51. PubMed ID: 16533567
[TBL] [Abstract][Full Text] [Related]
33. Endogenous melatonin is not obligatory for the regulation of the rat sleep-wake cycle.
Fisher SP; Sugden D
Sleep; 2010 Jun; 33(6):833-40. PubMed ID: 20550025
[TBL] [Abstract][Full Text] [Related]
34. The GABAA receptor agonist THIP alters the EEG in waking and sleep of mice.
Vyazovskiy VV; Kopp C; Bösch G; Tobler I
Neuropharmacology; 2005 Apr; 48(5):617-26. PubMed ID: 15814097
[TBL] [Abstract][Full Text] [Related]
35. Altered sleep latency and arousal regulation in mice lacking norepinephrine.
Hunsley MS; Palmiter RD
Pharmacol Biochem Behav; 2004 Aug; 78(4):765-73. PubMed ID: 15301933
[TBL] [Abstract][Full Text] [Related]
36. Melatonin treatment in adolescents with delayed sleep phase syndrome.
Szeinberg A; Borodkin K; Dagan Y
Clin Pediatr (Phila); 2006 Nov; 45(9):809-18. PubMed ID: 17041168
[TBL] [Abstract][Full Text] [Related]
37. Melatonin as a hypnotic: pro.
Zhdanova IV
Sleep Med Rev; 2005 Feb; 9(1):51-65. PubMed ID: 15649738
[TBL] [Abstract][Full Text] [Related]
38. Obestatin alters sleep in rats.
Szentirmai E; Krueger JM
Neurosci Lett; 2006 Aug; 404(1-2):222-6. PubMed ID: 16806691
[TBL] [Abstract][Full Text] [Related]
39. Effects of AP5 infusion into the lateral ventricle on the activities and hippocampal electrical patterns of sleep episodes in rats.
Melik E; Babar E; Guven M
Physiol Behav; 2006 Feb; 87(2):377-82. PubMed ID: 16376955
[TBL] [Abstract][Full Text] [Related]
40. Effects of exogenous melatonin on sleep: a meta-analysis.
Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I
Sleep Med Rev; 2005 Feb; 9(1):41-50. PubMed ID: 15649737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
